A. Tursi

Most-cited papers

1. A review on biomass: importance, chemistry, classification, and conversion

   A. Tursi

   2019Biofuel Research Journal634 citations Open access

   Semantic Scholar

   Save

2. Colonic diverticular disease

   A. Tursi, C. Scarpignato, L. Strate, Á. Lanas +3 more

   2020Nature Reviews Disease Primers159 citations Open access

   Semantic Scholar

   Save

3. COVID-19 infection in Crohn’s disease under treatment with adalimumab

   A. Tursi, G. Angarano, L. Monno, A. Saracino +3 more

   2020Gut55 citations Open access

   Semantic Scholar

   Save

4. Role of Inflammation in the Pathogenesis of Diverticular Disease

   A. Tursi, W. Elisei

   2019Mediators of Inflammation45 citations Open access

   Semantic Scholar

   Save

5. Pathogenesis of Diverticulosis and Diverticular Disease.

   J. Kupčinskas, L. Strate, G. Bassotti, G. Torti +5 more

   2020Journal of Gastrointestinal and Liver Diseases44 citations Open access

   Semantic Scholar

   Save

6. International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease.

   A. Tursi, G. Brandimarte, F. Di Mario, Á. Lanas +36 more

   2020Journal of Gastrointestinal and Liver Diseases40 citations Open access

   Semantic Scholar

   Save

7. Synthesis, Characterization and Mechanical Properties of Novel Bio-Based Polyurethane Foams Using Cellulose-Derived Polyol for Chain Extension and Cellulose Citrate as a Thickener Additive

   L. Maiuolo, F. Olivito, Vincenzo Algieri, P. Costanzo +6 more

   2021Polymers31 citations Open access

   Semantic Scholar

   Save

8. Cellulose citrate: a convenient and reusable bio-adsorbent for effective removal of methylene blue dye from artificially contaminated water

   F. Olivito, Vincenzo Algieri, Antonio Jiritano, M. A. Tallarida +4 more

   2021RSC Advances30 citations Open access

   Semantic Scholar

   Save

9. Synthesis and Enhanced Capture Properties of a New BioMOF@SWCNT‐BP: Recovery of the Endangered Rare‐Earth Elements from Aqueous Systems

   A. Tursi, T. F. Mastropietro, Rosaria Bruno, Mariafrancesca Baratta +6 more

   2021Advanced Materials Interfaces30 citations Open access

   Semantic Scholar

   Save

10. Totally green cellulose conversion into bio-oil and cellulose citrate using molten citric acid in an open system: synthesis, characterization and computational investigation of reaction mechanisms

    Isabella Romeo, F. Olivito, A. Tursi, Vincenzo Algieri +5 more

    2020RSC Advances30 citations Open access

    Semantic Scholar

    Save

11. Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.

    A. Tursi, G. Mocci, L. Allegretta, G. Aragona +46 more

    2022Inflammatory Bowel Diseases29 citations

    Semantic Scholar

    Save

12. Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

    A. Tursi, G. Mocci, R. Lorenzetti, L. Allegretta +25 more

    2021European Journal of Gastroenterology and Hepathology28 citations

    Semantic Scholar

    Save

13. Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study

    A. Tursi, G. Brandimarte, F. Di Mario, W. Elisei +37 more

    2021Gut25 citations Open access

    Semantic Scholar

    Save

14. Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19

    A. Tursi, L. Vetrone, A. Papa

    2020Inflammatory Bowel Diseases25 citations Open access

    Semantic Scholar

    Save

15. The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study

    A. Tursi, M. Franceschi, W. Elisei, M. Picchio +2 more

    2020Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology25 citations Open access

    Semantic Scholar

    Save

16. Current and Evolving Concepts on the Pathogenesis of Diverticular Disease.

    A. Tursi

    2019Journal of Gastrointestinal and Liver Diseases24 citations Open access

    Semantic Scholar

    Save

17. BTX Removal from Open Aqueous Systems by Modified Cellulose Fibers and Evaluation of Competitive Evaporation Kinetics

    A. Tursi, F. Chidichimo, Rita Bagetta, A. Beneduci

    2020Water22 citations Open access

    Semantic Scholar

    Save

18. Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers.

    A. Tursi, G. Mocci, R. Faggiani, L. Allegretta +20 more

    2019European journal of internal medicine22 citations

    Semantic Scholar

    Save

19. Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease

    A. Papa, A. Gasbarrini, A. Tursi

    2020American Journal of Gastroenterology21 citations Open access

    Semantic Scholar

    Save

20. Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers

    A. Tursi, G. Mocci, R. Faggiani, L. Allegretta +18 more

    2019Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology20 citations Open access

    Semantic Scholar

    Save

21. A novel catalytic two-step process for the preparation of rigid polyurethane foams: synthesis, mechanism and computational studies

    L. Maiuolo, F. Olivito, Fortuna Ponte, Vincenzo Algieri +5 more

    202119 citations

    Semantic Scholar

    Save

22. Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.

    A. Tursi, G. Mocci, A. Cuomo, L. Allegretta +38 more

    2021European Review for Medical and Pharmacological Sciences19 citations

    Semantic Scholar

    Save

23. Organic Matter Characterization and Phytotoxic Potential Assessment of a Solid Anaerobic Digestate Following Chemical Stabilization by an Iron-Based Fenton Reaction.

    A. Roccotelli, F. Araniti, A. Tursi, G. Di Rauso Simeone +5 more

    2020Journal of Agricultural and Food Chemistry19 citations Open access

    Semantic Scholar

    Save

24. COVID-19 as a Trigger for De Novo Crohn’s Disease

    A. Tursi, R. Nenna

    2021Inflammatory Bowel Diseases17 citations Open access

    Semantic Scholar

    Save

25. Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery

    A. Papa, A. Tursi, S. Danese, G. Rapaccini +2 more

    2020Journal of Clinical Medicine17 citations Open access

    Semantic Scholar

    Save

26. Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease

    E. Bretto, F. D'Amico, Walter Fiore, A. Tursi +1 more

    2022Journal of Clinical Medicine16 citations Open access

    Semantic Scholar

    Save

27. The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study

    A. Tursi, W. Elisei, M. Franceschi, M. Picchio +2 more

    2021European Journal of Gastroenterology and Hepathology16 citations

    Semantic Scholar

    Save

28. Influence of Three Extraction Methods on the Physicochemical Properties of Kefirans Isolated from Three Types of Animal Milk

    Chiara La Torre, Alessia Fazio, P. Caputo, A. Tursi +2 more

    2022Foods15 citations Open access

    Semantic Scholar

    Save

29. Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.

    A. Tursi, G. Mocci, A. Cuomo, A. Ferronato +46 more

    2022Journal of Gastrointestinal and Liver Diseases15 citations Open access

    Semantic Scholar

    Save

30. Risk factors for endoscopic severity of diverticular disease of the colon and its outcome: a real-life case-control study

    A. Tursi, A. Violi, G. Cambie', M. Franceschi +7 more

    2020European Journal of Gastroenterology and Hepathology15 citations

    Semantic Scholar

    Save

31. Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

    F. Bossa, G. Biscaglia, M. Valvano, G. Costantino +31 more

    2019Digestive Diseases and Sciences15 citations

    Semantic Scholar

    Save

32. Microbiota Composition in Diverticular Disease: Implications for Therapy

    A. Tursi, Valerio Papa, L. Lopetuso, C. Settanni +2 more

    2022International Journal of Molecular Sciences14 citations Open access

    Semantic Scholar

    Save

33. Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study

    A. Tursi, G. Mocci, L. Cingolani, E. Savarino +48 more

    2023Expert Opinion on Pharmacotherapy11 citations

    Semantic Scholar

    Save

34. Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study

    G. Mocci, A. Tursi, G. Maconi, G. Cataletti +60 more

    2023Expert Opinion on Biological Therapy11 citations

    Semantic Scholar

    Save

35. Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis

    A. Tursi, D. Piovani, G. Brandimarte, F. Di Mario +39 more

    2023United European Gastroenterology journal11 citations Open access

    Semantic Scholar

    Save

36. SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease

    A. Tursi, L. Lopetuso, L. Vetrone, A. Gasbarrini +1 more

    2022European Journal of Gastroenterology and Hepathology11 citations Open access

    Semantic Scholar

    Save

37. Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study

    G. Mocci, G. Bodini, L. Allegretta, A. Cazzato +12 more

    2022Biomedicines11 citations Open access

    Semantic Scholar

    Save

38. What's New in Diagnosing Diverticular Disease.

    D. Štimac, G. Nardone, A. Mazzari, A. Crucitti +5 more

    2020Journal of Gastrointestinal and Liver Diseases11 citations Open access

    Semantic Scholar

    Save

39. Improvement of Symptoms in Patients Affected by Chronic Atrophic Gastritis Using L-Cysteine (Acetium®)

    F. Di Mario, K. Rodríguez-Castro, M. Franceschi, S. Landi +6 more

    2022Digestive Diseases10 citations

    Semantic Scholar

    Save

40. Performance of a multi-compounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease.

    G. Brandimarte, G. Frajese, S. Bargiggia, D. Castellani +17 more

    2022Minerva gastroenterologica10 citations

    Semantic Scholar

    Save

41. Impact of anti-tnfα antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases

    A. Tursi, A. Papa

    2020Journal of Crohn's & Colitis10 citations Open access

    Semantic Scholar

    Save

42. Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis

    A. Tursi, D. Piovani, G. Brandimarte, F. Di Mario +39 more

    2023American Journal of Gastroenterology9 citations

    Semantic Scholar

    Save

43. The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study.

    A. Tursi, G. Brandimarte, F. Di Mario, Á. Lanas +34 more

    2020Journal of Gastrointestinal and Liver Diseases9 citations Open access

    Semantic Scholar

    Save

44. Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study

    A. Papa, F. Scaldaferri, M. Covino, A. Tursi +20 more

    2022Biomedicines8 citations Open access

    Semantic Scholar

    Save

45. Therapeutic Response to Adalimumab in a Case of Steroid-Dependent Segmental Colitis Associated With Diverticulosis.

    A. Tursi, R. Nenna, S. Danese

    2021American Journal of Gastroenterology8 citations

    Semantic Scholar

    Save

46. Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group

    F. Di Mario, P. Crafa, S. Grillo, S. Landi +5 more

    2022Acta bio-medica : Atenei Parmensis7 citations

    Semantic Scholar

    Save

47. Segmental Colitis Associated with Diverticulosis

    Rafael Luís Luporini, Marcel Domeniconi, Ana Carolina Parra, A. Rizzo +3 more

    2021Diverticular Disease Of The Colon – Recent Knowledge Of Physiopathology, Endoscopic Approaches, Clinical And Surgical Treatments [Working Title]7 citations Open access

    Semantic Scholar

    Save

48. EFFECT OF USTEKINUMAB ON EXTRAINTESTINAL DISEASES IN REFRACTORY CROHN'S DISEASE.

    A. Tursi, G. Mocci, G. Maconi

    2021Journal of Crohn's & Colitis7 citations

    Semantic Scholar

    Save

49. Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers

    M. Russo, K. Rodríguez-Castro, M. Franceschi, A. Ferronato +6 more

    2023International Journal of Molecular Sciences6 citations Open access

    Semantic Scholar

    Save

50. When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach

    A. Tursi, Valerio Papa, L. Lopetuso, L. Vetrone +2 more

    2022Journal of Personalized Medicine6 citations Open access

    Semantic Scholar

    Save